Published in Med Mal Infect on April 18, 2010
Evaluation of adult dTPaP vaccination coverage in France: experience in Lyon city, 2010-2011. BMC Public Health (2012) 0.79
A survey of French general practitioners on the epidemiology of wounds in family practice. Int J Gen Med (2015) 0.77
[Analysis of vaccination data of patients aged 60 years and older from Bavaria and Thuringia]. Z Gerontol Geriatr (2015) 0.76
Vaccine knowledge in students in Paris, France, and surrounding regions. Can J Infect Dis Med Microbiol (2014) 0.75
Spotlight on measles 2010: update on the ongoing measles outbreak in France, 2008-2010. Euro Surveill (2010) 2.40
Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. JAMA (1998) 2.37
Serological effects of Edmonston-Zagreb, Schwarz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months. Lancet (1989) 2.11
Outbreak of hand, foot and mouth disease/herpangina associated with coxsackievirus A6 and A10 infections in 2010, France: a large citywide, prospective observational study. Clin Microbiol Infect (2012) 1.79
The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol Infect (2005) 1.60
First cases of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infections in France, investigations and implications for the prevention of human-to-human transmission, France, May 2013. Euro Surveill (2013) 1.55
Surveillance of enteroviruses in France, 2000-2004. Eur J Clin Microbiol Infect Dis (2007) 1.38
Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009. Euro Surveill (2010) 1.37
Estimation of measles reproduction ratios and prospects for elimination of measles by vaccination in some Western European countries. Epidemiol Infect (2001) 1.36
Influenza A(H1N1)pdm09 vaccination policies and coverage in Europe. Euro Surveill (2012) 1.28
Early estimates of 2009 pandemic influenza A(H1N1) virus activity in general practice in France: incidence of influenza-like illness and age distribution of reported cases. Euro Surveill (2009) 1.23
Prevalence of hepatitis C and hepatitis B infection in the HIV-infected population of France, 2004. Euro Surveill (2008) 1.11
Invasive group B streptococcal infections in adults, France (2007-2010). Clin Microbiol Infect (2011) 1.07
The seroepidemiology of measles in Western Europe. Epidemiol Infect (2001) 1.04
Influence of vaccination coverage on pertussis transmission in France. Lancet (1999) 1.03
Epidemiology of invasive Streptococcus pyogenes infections in France in 2007. J Clin Microbiol (2011) 1.02
Adult intensive-care patients with 2009 pandemic influenza A(H1N1) infection. Epidemiol Infect (2010) 0.98
Low coverage of seasonal influenza vaccination in the elderly in many European countries. Euro Surveill (2008) 0.98
Three ECHOvirus serotypes responsible for outbreak of aseptic meningitis in Rhône-Alpes region, France. Eur J Clin Microbiol Infect Dis (2003) 0.96
Serogroup C invasive meningococcal disease among men who have sex with men and in gay-oriented social venues in the Paris region: July 2013 to December 2014. Euro Surveill (2015) 0.96
Measles resurgence in France in 2008, a preliminary report. Euro Surveill (2009) 0.95
Measles outbreak in a refugee settlement in Calais, France: January to February 2016. Euro Surveill (2016) 0.93
The cost of measles in industrialised countries. Vaccine (2003) 0.91
Mandatory immunization: the point of view of the French general population and practitioners. Vaccine (2008) 0.87
Barriers to implementation of the new targeted BCG vaccination in France: a cross sectional study. Vaccine (2011) 0.85
Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui. Int J Epidemiol (1995) 0.85
The current status of HPV and rotavirus vaccines in national immunisation schedules in the EU--preliminary results of a VENICE survey. Euro Surveill (2007) 0.84
Vaccine coverage of pre-school age children in France in 2000. Euro Surveill (2003) 0.81
[Vaccinal efficacy: measures and methodological constraints]. Sante (1994) 0.81
[Modelling the impact of vaccination on the epidemiology of varicella zoster virus]. Rev Epidemiol Sante Publique (2008) 0.81
Practical field epidemiology to investigate a cholera outbreak in a Mozambican refugee camp in Malawi, 1988. J Trop Med Hyg (1991) 0.79
Introduction of human papillomavirus (HPV) vaccination into national immunisation schedules in Europe: Results of the VENICE 2007 survey. Euro Surveill (2008) 0.79
[Vaccination coverage in 6-year-old preschool children, France, 2005-2006]. Arch Pediatr (2013) 0.79
Outbreak of measles in two private religious schools in Bourgogne and Nord-Pas-de-Calais regions of France, May-July 2008 (preliminary results). Euro Surveill (2008) 0.78
[BCG vaccine coverage in private medical practice: First data in children below two years old, seven months after the end of compulsory vaccination in France]. Arch Pediatr (2009) 0.77
[BCG vaccine and place of tuberculin skin test in 2006]. Rev Med Interne (2006) 0.77
Validity of self-reported vaccination status among French healthcare students. Clin Microbiol Infect (2014) 0.76
[BCG vaccination coverage in children born after the end of compulsory BCG vaccination and followed in maternal and child health clinics in France: a national survey 2009]. Arch Pediatr (2010) 0.75
Impact of free on-site vaccine and/or healthcare workers training on hepatitis B vaccination acceptability in high-risk subjects: a pre-post cluster randomized study. Clin Microbiol Infect (2014) 0.75
[Vaccination: choosing between individual desire and public policy]. Rev Epidemiol Sante Publique (2005) 0.75
Impact of the BCG vaccination policy on tuberculous meningitis in children under 6 years in metropolitan France between 2000 and 2011. Euro Surveill (2015) 0.75
[Vaccination strategies of tomorrow... is it necessary to revaccinate rubella, mumps and rubeola, and when?]. Arch Pediatr (1998) 0.75
[Increased incidence of invasive meningococcal disease in Seine-Maritime. The evolving epidemiology due to the B:14:P1.7,16 strain]. Arch Pediatr (2007) 0.75
[Decision regarding vaccination]. Rev Epidemiol Sante Publique (1995) 0.75
Are European immunisation programmes recession proof? Euro Surveill (2011) 0.75
[Invasive Streptococcus pyogenes infections]. Med Mal Infect (2004) 0.75
[The risks of a mismanaged immunization program: the example of vaccination against rubella]. Rev Epidemiol Sante Publique (2000) 0.75
[Comparative serological efficacy of the measles vaccine strains Edmonston-Zagreb, Schwarz and AIK-C in Togolese infants of 4-5 months and 8-10 months]. Bull Soc Pathol Exot (1991) 0.75
Hepatitis B virus transmission from a nurse to a patient, France, 2005. Euro Surveill (2008) 0.75
Assessing BCG vaccination coverage and incidence of paediatric tuberculosis following two major changes in BCG vaccination policy in France. Euro Surveill (2011) 0.75
[Epidemiology of rubella in France, 20 years after the advent of vaccination]. Rev Prat (2000) 0.75
[Vaccinations. Immunologic and microbiologic principles, indications, contraindications, accidents, efficacy (schedule and compulsory aspects of vaccination excluded)]. Rev Prat (1998) 0.75
[What place for BCG vaccination in France?]. Arch Pediatr (2002) 0.75
[Expanded program of vaccination. Results and prospects]. Ann Med Interne (Paris) (1998) 0.75
[Risks of accidental exposure to blood in the operating room. Results of a multicenter prospective study. Groupe d'Etude sur les Risques d'Exposition au Sang]. Ann Chir (1995) 0.75
[Occupational risk of exposure to blood in nurses. Results of a one-year monitoring of the risk for nurses in 17 hospitals]. Pathol Biol (Paris) (1992) 0.75
[Drug resistance in malaria, what to do? Apropos of 3 cases]. Bull Soc Pathol Exot Filiales (1985) 0.75